PeproMene Bio is a virtual, privately funded biotech company .
PeproMene Bio has raised $5.0M in total funding. The most recent round was Corporate Round. The last funding was announced in December 2024.
PeproMene Bio's investors include Institute for Follicular Lymphoma Innovation.
PeproMene Bio is headquartered in Irvine, United States.
PeproMene Bio is a virtual, privately funded biotech company .
PeproMene Bio is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PeproMene Bio — Funding & Investors." VCBacked, December 18, 2024, https://www.vcbacked.co/company/pepromene-bio. Accessed September 29, 2026.
VCBacked. (2024). PeproMene Bio — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/pepromene-bio
{{cite web |title=PeproMene Bio — Funding & Investors |url=https://www.vcbacked.co/company/pepromene-bio |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated